WeLeader Biomedical Co., Ltd. (7713)
Market Closed
14 Oct, 05:30 AM
TWSE 
JPX Primary TWSE NT$
73. 00
0
0%
NT$
- Market Cap
- P/E Ratio
42% Div Yield
7,112 Volume
- Eps
NT$ 73
Previous Close Want to track 7713 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
WeLeader Biomedical Co., Ltd. (7713) Statistics
Valuation metrics
Market Cap -
Enterprise value 4.21B
Trailing P/E (ttm) 13.3
Forward P/E -
PEG ratio 0.38
Price/Sales (ttm) 2.75
Price/Book (mrq) 2.76
Enterprise Value/Revenue 3.48
Enterprise Value/EBITDA 9.53
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.03K
Average volume (90 days) 8.06K
Price summary
52-Week low 66
52-Week high 81.1
Beta -
50-Day moving average 73.72
200-Day moving average 70.59
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 4.1
Trailing annual dividend yield 0.0562%
5-Year annual dividend yield -
Payout ratio 0.75
Dividend Date 27 Apr 2026
Ex-Dividend Date 27 Mar 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.21%
Operating margin 0.26%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.21%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 26.66
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 5.5
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.71
Total debt (mrq) -
Total Debt/Equity (mrq) 0.82
Current ratio (mrq) 1.55%
Book value per share (mrq) 26.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
